Role of AQP4 mediated glymphatic system dysfunction in postoperative neuroinflammation and cognitive dysfunction
- Brain Behav Immun. 2026 May 8:137:106797. doi: 10.1016/j.bbi.2026.106797.
- 1. Department of Anesthesiology, Ningbo No. 2 Hospital, Ningbo, Zhejiang 315010, China; Health Science Center, Ningbo University, Ningbo, Zhejiang 315211, China.
- 2. Department of Anesthesia and Surgery, Hunan Chest Hospital, Changsha, Hunan 410013, China.
- 3. Health Science Center, Ningbo University, Ningbo, Zhejiang 315211, China.
- 4. Department of Anesthesiology, Ningbo No. 2 Hospital, Ningbo, Zhejiang 315010, China.
- 5. Department of Pain, Ningbo No. 2 Hospital, Ningbo, Zhejiang 315010, China.
- 6. Department of Anesthesiology, Ningbo No. 2 Hospital, Ningbo, Zhejiang 315010, China. Electronic address: [email protected].
- 7. Health Science Center, Ningbo University, Ningbo, Zhejiang 315211, China. Electronic address: [email protected].
- 8. Department of Anesthesiology, Ningbo No. 2 Hospital, Ningbo, Zhejiang 315010, China. Electronic address: [email protected].
Postoperative cognitive dysfunction (POCD) is a common complication in surgical patients, particularly those with pre-existing chronic inflammation. Although impaired glymphatic clearance, a brain waste drainage system dependent on astrocytic aquaporin-4 (AQP4) polarization, is implicated in neurodegenerative disorders, its role in POCD pathogenesis and interaction with neuroinflammation remains unknown. Here, we investigated whetherglymphatic dysfunctiondrives postoperative neuroinflammation and cognitive deficits using a "dual-hit inflammation"model.Our results revealed glymphatic influx/efflux was severely impaired, reaching its lowest point 24 h postoperatively, and gradually recovered by day 7, preceding peak neuroinflammation. AQP4 depolarization correlated with glymphatic dysfunction. Pharmacological AQP4 inhibition (TGN-020)exacerbated glymphatic dysfunction, prolonged cytokine accumulation, and worsened cognitive deficits. HippocampalAQP4 overexpression restored glymphatic clearance, reduced neuroinflammation, and rescued cognition. These findings establish AQP4-mediated glymphatic impairment as an upstream driver of neuroinflammation in POCD, revealing a novel therapeutic target for high-risk surgical patients.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: PROTAC Linkers